Talkspace (TALK) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
9 Mar, 2026Executive summary
Universal Health Services (UHS) has entered into a definitive agreement to acquire Talkspace for $5.25 per share, valuing the transaction at approximately $835 million, to be financed through UHS's existing credit facility.
The acquisition aims to create a nationally scaled, end-to-end continuum in behavioral healthcare, expanding access and integrating virtual and outpatient services.
Talkspace, with 6,000 licensed professionals, generated $229 million in revenue and delivered over 1.6 million therapy and psychiatry sessions in 2025.
The transaction is expected to be slightly accretive to UHS's adjusted net income per diluted share in the first year post-closing and increasingly accretive thereafter.
Closing is anticipated in the third quarter of 2026, pending shareholder and regulatory approvals.
Voting matters and shareholder proposals
The merger requires approval by Talkspace's stockholders, with proxy materials to be filed and distributed for voting.
Investors are urged to review the proxy statement and related SEC filings for important information regarding the transaction.
Board of directors and corporate governance
The transaction was unanimously approved by the Boards of Directors of both UHS and Talkspace.
Directors, executive officers, and certain employees may be deemed participants in the proxy solicitation for the merger.
Latest events from Talkspace
- Q2 2026 revenue grew 13.6% YoY to $61.7M, with a pending $835M merger with UHS.TALK
Q2 2026 - Revenue up 18%, net loss from merger costs, UHS acquisition expected Q3 2026.TALK
Q1 2026 - Board unanimously recommends approval of $5.25/share cash merger with UHS; key holders support.TALK
Proxy filing - Stockholders to vote on $5.25/share cash merger with UHS, with board unanimous support and fairness opinion.TALK
Proxy filing - Definitive agreement for acquisition by UHS to create a national behavioral health continuum.TALK
Proxy Filing - Shareholders to receive $5.25 per share in all-cash merger, pending approvals and clearances.TALK
Proxy Filing - Q3 2025 saw 25% revenue growth, 111% higher adjusted EBITDA, and raised full-year guidance.TALK
Q3 2025 - Q3 revenue up 23% YoY, net income positive, and Payor segment drives growth and expansion.TALK
Q3 2024 - Q1 2025 revenue up 15% year-over-year, Payor segment drove growth, net income positive.TALK
Q1 2025